Effect of sequential chemotherapy and gefitinib on survival outcome in advanced NSCLC with acquired gefitinib resistance.

Wang Hui-juan,Zhang Mina,Zhang Guo-wei,Zhu Hui,Wang Qiming,Li Peng,Yan Xiangtao,Li Shaomei,Ma Zhi-yong

Effect of sequential chemotherapy and gefitinib on survival outcome in advanced NSCLC with acquired gefitinib resistance.

2017

Wang Hui-juan
Zhang Mina
Zhang Guo-wei
Zhu Hui
Wang Qiming
Li Peng
Yan Xiangtao
Li Shaomei
Ma Zhi-yong

e19085 Background: As one of the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), gefitinib has been proven to be highly effective for patients with advanced NSCLC. However, a...

Keywords:

Pathology
Epidermal growth factor receptor
Tyrosine-kinase inhibitor
Gefitinib
Cancer research
Medicine
Chemotherapy
epidermal growth factor receptor tyrosine kinase
survival outcome
gefitinib resistance
sequential chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations